Jiro Yamana

1.4k total citations
17 papers, 1.0k citations indexed

About

Jiro Yamana is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jiro Yamana has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jiro Yamana's work include Chemokine receptors and signaling (4 papers), Immune Response and Inflammation (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Jiro Yamana is often cited by papers focused on Chemokine receptors and signaling (4 papers), Immune Response and Inflammation (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Jiro Yamana collaborates with scholars based in Japan, Australia and United States. Jiro Yamana's co-authors include Masahiro Yamamura, Hirofumi Makino, Katsue Sunahori, Masanori Kawashima, Mitsuhiro Iwahashi, Eric F. Morand, Satoru Yui, Walter Chazin, Hiroshi Yamamoto and Leilani L. Santos and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Arthritis Research & Therapy.

In The Last Decade

Jiro Yamana

17 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Yamana Japan 14 449 417 237 153 143 17 1.0k
Jens Gerwien Denmark 17 448 1.0× 295 0.7× 110 0.5× 173 1.1× 261 1.8× 33 1.1k
Jack Hutcheson United States 22 654 1.5× 461 1.1× 246 1.0× 303 2.0× 58 0.4× 37 1.3k
René Huber Germany 16 249 0.6× 420 1.0× 284 1.2× 189 1.2× 49 0.3× 39 957
Kim L. L. Habets Netherlands 20 633 1.4× 359 0.9× 179 0.8× 170 1.1× 74 0.5× 27 1.1k
Chie Miyabe Japan 16 309 0.7× 277 0.7× 227 1.0× 137 0.9× 68 0.5× 34 882
Ilan Ifergan Israel 18 212 0.5× 390 0.9× 251 1.1× 397 2.6× 86 0.6× 20 1.1k
Myoungsun Son United States 18 675 1.5× 293 0.7× 98 0.4× 124 0.8× 51 0.4× 25 1.1k
Weronika Kurowska Poland 16 328 0.7× 388 0.9× 370 1.6× 178 1.2× 99 0.7× 27 1.0k
Katsue Sunahori Japan 10 342 0.8× 316 0.8× 203 0.9× 93 0.6× 37 0.3× 10 647
Xiaoping Qing United States 15 540 1.2× 237 0.6× 390 1.6× 217 1.4× 41 0.3× 23 1.1k

Countries citing papers authored by Jiro Yamana

Since Specialization
Citations

This map shows the geographic impact of Jiro Yamana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Yamana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Yamana more than expected).

Fields of papers citing papers by Jiro Yamana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Yamana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Yamana. The network helps show where Jiro Yamana may publish in the future.

Co-authorship network of co-authors of Jiro Yamana

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Yamana. A scholar is included among the top collaborators of Jiro Yamana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Yamana. Jiro Yamana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mokuda, Sho, Yusuke Yoshida, Jiro Yamana, et al.. (2020). Serum CXCL10 levels are associated with better responses to abatacept treatment of rheumatoid arthritis.. PubMed. 38(5). 956–963. 7 indexed citations
2.
Nagamoto, Yasutsugu, et al.. (2018). Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole. JCR Journal of Clinical Rheumatology. 24(7). 355–360. 16 indexed citations
4.
Song, Soken-Nakazawa J., Mitsuhiro Iwahashi, Naohisa Tomosugi, et al.. (2013). Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. Arthritis Research & Therapy. 15(5). R141–R141. 117 indexed citations
5.
Yamana, Jiro, et al.. (2011). Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes. Cellular Immunology. 272(2). 293–298. 17 indexed citations
6.
Yamana, Jiro, Leilani L. Santos, & Eric F. Morand. (2008). Enhanced induction of LPS-induced fibroblast MCP-1 by interferon-γ: Involvement of JNK and MAPK phosphatase-1. Cellular Immunology. 255(1-2). 26–32. 19 indexed citations
7.
Santos, Leilani L., et al.. (2008). Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clinical & Experimental Immunology. 152(2). 372–380. 39 indexed citations
8.
Yamamura, Masahiro, et al.. (2007). Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.. PubMed. 61(2). 89–98. 56 indexed citations
9.
Sunahori, Katsue, Masahiro Yamamura, Jiro Yamana, et al.. (2006). The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Research & Therapy. 8(3). R69–R69. 267 indexed citations
10.
Takasugi, Koji, Masahiro Yamamura, Mitsuhiro Iwahashi, et al.. (2006). Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis. Arthritis Research & Therapy. 8(4). R126–R126. 18 indexed citations
11.
Yamamura, Masahiro, et al.. (2006). Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.. PubMed. 60(3). 149–57. 26 indexed citations
12.
Hoi, Alberta, Michael J. Hickey, Pamela Hall, et al.. (2006). Macrophage Migration Inhibitory Factor Deficiency Attenuates Macrophage Recruitment, Glomerulonephritis, and Lethality in MRL/lpr Mice. The Journal of Immunology. 177(8). 5687–5696. 102 indexed citations
13.
Sunahori, Katsue, Masahiro Yamamura, Jiro Yamana, et al.. (2005). Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis & Rheumatism. 54(1). 97–104. 67 indexed citations
14.
Nishida, Keiichiro, Takamitsu Komiyama, Shin‐Ichi Miyazawa, et al.. (2004). Histone deacetylase inhibitor suppression of autoantibody‐mediated arthritis in mice via regulation of p16INK4a and p21WAF1/Cip1 expression. Arthritis & Rheumatism. 50(10). 3365–3376. 184 indexed citations
15.
Yamana, Jiro, Masahiro Yamamura, Akira Okamoto, et al.. (2004). Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+T cells from patients with rheumatoid arthritis. Arthritis Research & Therapy. 6(6). R567–77. 22 indexed citations
16.
Aita, Tetsushi, Masahiro Yamamura, Masanori Kawashima, et al.. (2004). Expression of interleukin 12 receptor (IL-12R) and IL-18R on CD4+ T cells from patients with rheumatoid arthritis.. PubMed. 31(3). 448–56. 11 indexed citations
17.
Okamoto, Akira, Masahiro Yamamura, Mitsuhiro Iwahashi, et al.. (2003). Pathophysiological functions of CD30+ CD4+ T cells in rheumatoid arthritis.. PubMed. 57(6). 267–77. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026